A New Diabetes Cure was Found in a Weight Loss Drug

Share

9 percent or more than 30 million people of the United States of America’s population are living with diabetes based on reports from Centers for Disease Control and Prevention.

If we are also considering the prediabetes, according to the Centers for Disease Control and Prevention, the number rises to more than 100 million U.S. adults.

Unfortunately, there are not many options a person suffering from diabetes can choose from to treat their disease. They can have surgical interventions for weight loss, swallow oral drugs such as metformin and also many types of insulin.

During an event held in Berlin, the 2018 Meeting of the European Association for the Study of Diabetes, research was presented, and it showed that this treatment arsenal might need to welcome a new addition.

This addition might be the lorcaserin, a weight loss drug which the researchers suggest that can reduce the risk of getting complications from diabetes, lower the risk of developing this condition, and induce diabetes remission. These facts were proven during the team of researchers’ clinical trial held at Women’s Hospital (BWH) in Boston, MA.

The trial was conducted by the BWH scientists from the Thrombolysis in Myocardial Infarction (TIMI) Study Group who presented their findings from the clinical trial named CAMELLIA-TIMI 61. The trial was funded by the company that manufactures the drug, Eisai Inc.

A BWH cardiovascular medicine specialist and a staff investigator for the TIMI Study Group, Dr. Erin Bohula co-led the research together with Dr. Benjamin Scirica, another cardiovascular medicine specialist at BWH and senior investigator for the TIMI Study Group.

This research can revolutionize the way people suffering from diabetes are treated, and maybe in the future, this drug will be able to help with other diseases as well.


Share

Recommended For You

Leave a Reply

Your email address will not be published. Required fields are marked *